Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma
- 28 February 2006
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 42 (3), 342-350
- https://doi.org/10.1016/j.ejca.2005.10.008
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Fast Whole-Body Assessment of Metastatic Disease Using a Novel Magnetic Resonance Imaging SystemInvestigative Radiology, 2005
- Defining Adequate Surgery for Primary MelanomaThe New England Journal of Medicine, 2004
- Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in OncologyJAMA, 2003
- Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trialsThe Lancet Oncology, 2003
- Current Concepts in Whole-Body Imaging Using Turbo Short Tau Inversion Recovery MR ImagingAmerican Journal of Roentgenology, 2003
- Three-Dimensional Volumetric Interpolated Breath-Hold MR Imaging for Whole-Body Tumor Staging in Less Than 15 Minutes: A Feasibility StudyAmerican Journal of Roentgenology, 2002
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging SystemJournal of Clinical Oncology, 2001
- Computed Tomography Features of Cerebral Spread of Malignant MelanomaAmerican Journal of Clinical Oncology, 1996
- Metastatic disease in patients with newly diagnosed malignant melanomaJournal of Surgical Oncology, 1987
- Metastatic pattern of malignant melanoma: A study of 216 autopsy casesThe American Journal of Surgery, 1978